Aluminum is a potential environmental factor for crohn's disease induction: Extended hypothesis

Annals of the New York Academy of Sciences

Volumn 1107, Issue , 2007, Pages 329-345

  Lerner, Aaron ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

Author keywords

Aluminum; Crohn's disease; Environmental factor; Inflammation; Intestine; Mucosal immunology

Indexed keywords

ALUMINUM;

ANTIGEN PRESENTING CELL; BACTERIAL VIRULENCE; CELL ACTIVATION; CELL ACTIVITY; CELLULAR IMMUNITY; CONFERENCE PAPER; CROHN DISEASE; DIET; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; GRANULOMA; HUMAN; HUMORAL IMMUNITY; HYPOTHESIS; ILEUM; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; INCIDENCE; INTESTINE FLORA; MUCOSAL IMMUNITY; NONHUMAN; POLLUTION; PREVALENCE; PROTEIN EXPRESSION; RECURRENT DISEASE; TH1 CELL; URBAN AREA; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; IMMUNE SYSTEM; IMMUNOLOGY; PATHOLOGY;

ANIMALIA; BACTERIA (MICROORGANISMS);

ALUMINUM; ANIMALS; CROHN DISEASE; HUMANS; ILEUM; IMMUNE SYSTEM;

EID: 34648829235     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1381.035     Document Type: Conference Paper

References (96)

1. SARTOR, R.B. 2001. Induction of mucosal immune responses by bacteria and bacterial components. Curr. Opin. Gastroenterol. 17: 555-561.
2. POWELL, J.J., J. VAN DE WATER & M.E. GERSHWIN. 1999. Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions. Environ. Health Perspect. 107(Suppl 5): 667-672.
3. D'CRUZ, D. 2000. Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol. Lett. 112-113: 421-432.
4. KOSUDA, L.L., D.L. GREINER & P.E. BIGAZZI. 1993. Mercury-induced renal autoimmunity: changes in RT6+ T-lymphocytes of susceptible and resistant rats. Environ. Health Perspect. 101: 178-185.
5. HAGGQVIST, B. & P. HULTMAN. 2003. Effects of deviating the Th2-response in murine mercury-induced autoimmunity towards a Th1-response. Clin. Exp. Immunol. 134: 202-209.
6. EPSTEIN, P.E., J.H. DAUBER, M.D. ROSSMAN, et al. 1982. Bronchoalveolar lavage in a patient with chronic berylliosis: evidence for hypersensitivity pneumonitis. Ann. Intern. Med. 97: 213-216.
7. KREISS, K., S. WASSERMAN, M.M. MROZ, et al. 1993. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations. J. Occup. Med. 35: 267-274.
8. EPSTEIN, W.L., J.R. SKAHEN & H. KRASNOBROD. 1963. Granulomatous hypersensitivity to zirconium: localization of allergen in tissue and its role in formation of epithelioid cells. J. Invest. Dermatol. 38: 223-232.
9. PRICE, E.W. & D.A. PLANT. 1990. The significance of particle size of soils as a risk factor in the etiology of podoconiosis. Trans. R. Soc. Trop. Med. Hyg. 84: 885-886.
10. MCCOY, K.L., M. NOONE, J.K. INMAN, et al. 1993. Exogenous antigens internalized through transferrin receptors activate CD4+ T cells. J. Immunol. 150: 1691-1704.
11. RICHELDI, L., R. SORRENTINO & C. SALTINI. 1993. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 262: 242-244.
12. ARMSTRONG, R.A., S.J. WINSPER & J.A. BLAIR. 1995. Hypothesis: is Alzheimer's disease a metal-induced immune disorder? Neurodegeneration 4: 107-111.
13. SMITH, K.M., J.M. BREWER & C.M. RUSH. 2004. In vivo generated Th1 cells can migrate to B cell follicles to support B cell responses. J. Immunol. 173: 1640-1646.
14. OSINSKA, E., D. KANONIUK & A. KUSIAK. 2004. Aluminum hemotoxicity mechanisms. Ann. Univ. Mariae Curie Sklodowska 59: 411-416.
15. PERL, D.P., U. FOGARTY, N. HARPAZ, et al. 2004. Bacterial-metal interactions: the potential role of aluminum and other trace elements in the etiology of Crohn's disease. Inflamm. Bowel Dis. 10: 881-883.
16. LOMER, M.C., R.P. THOMPSON & J.J. POWELL. 2002. Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease. Proc. Nutr. Soc. 61: 123-130.
17. BECARIA, A., A. CAMPBEL & S.C. BONDY. 2002. Aluminum as a toxicant. Toxicol. Ind. Health. 18: 309-320.
18. NAYAK, P. 2002. Aluminum: impacts and disease. Environ. Res. 89: 101-115.
19. EXLEY, C., A. BEGUM, M.P. WOOLLEY, et al. 2006. Aluminum in tobacco and cannabis and smoking-related disease. Am. J. Med. 119: 276, e9-e11.
20. DOBRANSKYTE, A., R. JUGDAOHSINGH & C.R. MCCROHAN. 2006. Effect of humic acid on water chemistry, bioavailability and toxicity of aluminium in the freshwater snail, Lymnaea stagnalis, at neutral pH. Environ. Pollut. 140: 340-347.
21. STOEHR, G., K. LUEBBERS & M. WILHELM. 2006. Aluminum load in ICU patients during stress ulcer prophylaxis. Eur. J. Intern. Med. 17: 561-566.
22. MALAKOFF, D. 2000. Aluminum is put on trial as a vaccine booster. Science 288: 1323-1324.
23. VENTURINI-SORIANO, M. & G. BERTHON. 2001. Aluminum speciation studies in biological fluids. Part 7. A quantitative investigation of aluminum(III)-glutamate complex equilibria and their potential implications for aluminum metabolism and toxicity. J. Inorg. Biochem. 85: 143-154.
24. DAYDE, S., V. BRUMAS, D. CHAMPMARTIN, et al. 2003. Aluminum speciation studies in biological fluids. Part 9. A quantitative investigation of aluminum(III)-glutamate complex equilibria and their potential implications for aluminum metabolism and toxicity. J. Inorg. Biochem. 97: 104-117.
25. DESROCHES, S., S. DAYDE & G. BERTHON. 2000. Aluminum speciation studies in biological fluids. Part 6. Quantitative investigation of aluminum(III)-tartrate complex equilibria and their potential implications for aluminum metabolism and toxicity. J. Inorg. Biochem. 81: 301-312.
26. CUNAT, L., M.C. LANHERS, M. JOYEUX, et al. 2000. Bioavailability and intestinal absorption of aluminum in rats: effects of aluminum compounds and some dietary constituents. Biol. Trace Elem. Res. 76: 31-55.
27. POWELL, J.J., M.W. WHITEHEAD, C.C. AINLEY, et al. 1999. Dietary minerals in the gastrointestinal tract: hydroxypolymerisation of aluminium is regulated by luminal mucins. J. Inorg. Biochem. 75: 167-180.
28. TAYLOR, G.A., P.B. MOORE & I.N. FERRIER. 1998. Gastrointestinal absorption of aluminium and citrate in man. J. Inorg. Biochem. 69: 165-169.
29. DRUEKE, T.B. 2002. Intestinal absorption of aluminium in renal failure. Nephrol. Dial. Transplant. 17(Supp. 2): 13-16.
30. WHITEHEAD, M.W., G. FARRAR, G.L. CHRISTIE, et al. 1997. Mechanisms of aluminum absorption in rats. Am. J. Clin. Nutr. 65: 1446-1452.
31. FLOREN, C., L. TEKAYA, F. ESCAIG, et al. 2001. Analytical microscopy observations of rat enterocytes after oral administration of soluble salts of lanthanides, actinides and elements of group III-A of the periodic chart. Cell. Mol. Biol. 47: 419-425.
32. MOREFIELD, G.L., A. SOKOLOVSKA, D. JIANG, et al. 2005. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine 23: 1588-1595.
33. SHI, Y., H. HOGENESCH & S.L. HEM. 2001. Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines. Vaccine 20: 80-85.
34. ULANOVA, M., A. TARKOWSKI, M. HAHN-ZORIC, et al. 2001. The common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4- dependent mechanism. Infect. Immun. 69: 1151-1159.
35. RIMANIOL, A.C., G. GRAS & F. VERDIER. 2004. Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type. Vaccine 22: 3127-3135.
36. SAUTER, B., M.L. ALBERT, L. FRANCISCO, et al. 2000. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191: 423-434.
37. BREWER, J.M. 2006. (How) do aluminium adjuvants work? Immunol. Lett. 102: 10-15.
38. SMITH, K.M., P. GARSIDE, R.C. MCNEIL, et al. 2006. Analysis of costimulatory molecule expression on antigen-specific T and B cells during the induction of adjuvant-induced Th1 and Th2 type responses. Vaccine 24: 3035-3043.
39. HOGENESCH, H. 2002. Mechanisms of stimulation of the immune response by aluminum adjuvants. Vaccine 20: S34-S39.
40. JANKOVIC, D., P. CASPAR, M. ZWEIG, et al. 1997. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120. J. Immunol. 159: 2409-2417.
41. COOPER, D., M.W. PRIDE, M. GUO, et al. 2004. Interleukin-12 redirects murine immune responses to soluble or aluminum phosphate adsorbed HSV-2 glycoprotein D towards Th1 and CD4+ CTL responses. Vaccine 23: 236-246.
42. DAVIS, H.L., R. WEERATNA, T.J. WALDSCHMIDT, et al. 1998. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160: 870-876.
43. ZHANG, Y., G.H. PALMER, J.R. ABBOTT, et al. 2003. CpG ODN 2006 and IL-12 are comparable for priming Th1 lymphocyte and IgG responses in cattle immunized with a rickettsial outer membrane protein in alum. Vaccine 21: 3307-3318.
44. ULMER, J.B., C.M. DEWITT, M. CHASTAIN et al. 1999. Enhancement of DNA vaccine potency using conventional aluminum adjuvants. Vaccine. 18: 18-28.
45. COOPER, P.D. 1995. Vaccine adjuvants based on gamma inulin. Pharm. Biotechnol. 6: 559-580.
46. PETROVSKY, N. 2006. Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity. Vaccine 24(Suppl 2): 26-29.
47. ROBERFROID, M.B. 2005. Introducing inulin-type fructans. Br. J. Nutr. 93(Suppl 1): S13-S25.
48. IGLESIAS, E., O. FRANCH & Y. CARRAZANA. 2006. Influence of aluminum-based adjuvant on the immune response to multiantigenic formulation. Viral Immunol. 19: 712-721.
49. WARD, R.J., C.R. MCCROHAN & K.N. WHITE. 2006. Influence of aqueous aluminium on the immune system of the freshwater crayfish Pacifasticus leniusculus. Aquat. Toxicol. 77: 222-228.
50. ASHWOOD, P., R.P. THOMPSON & J.J. POWELL. 2007. Fine particles that adsorb lipopolysaccharide via bridging calcium cations may mimic bacterial pathogenicity towards cells. Exp. Biol. Med. 232: 107-117.
51. VOGELBRUCH, M., B. NUSS & M. KORNER. 2000. Aluminium-induced granulomas after inaccurate intradermal hyposensitization injections of aluminium-adsorbed depot preparations. Allergy 55: 883-887.
52. RIVAS, E., M. GOMEZ-ARNAIZ & J.R. RICOY. 2005. Macrophagic myofasciitis in childhood: a controversial entity. Pediatr. Neurol. 33: 350-356.
53. CHONG, H., K. BRADY & D. METZE. 2006. Persistent nodules at injection sites (aluminium granuloma) - clinicopathological study of 14 cases with a diverse range of histological reaction patterns. Histopathology 48: 182-188.
54. CHEN, W.J., R.J. MONNAT Jr., M. CHEN, et al. 1978. Aluminum induced pulmonary granulomatosis. Hum. Pathol. 9: 705-711.
55. SHEPHERD, N.A., P.R. CROCKER & A.P. SMITH. 1987. Exogenous pigment in Peyer's patches. Hum. Pathol. 18: 50-54.
56. URBANSKI, S.J., A.L. ARSENAULT & F.H. GREEN. 1989. Pigment resembling atmospheric dust in Peyer's patches. Mod. Pathol. 2: 222-226.
57. POWELL, J.J., C.C. AINLEY & R.S. HARVEY. 1996. Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut 38: 390-395.
58. CHESS, S., D. CHESS, G. OLANDER, et al. 1950. Production of chronic enteritis and other systemic lesions by ingestion of finely divided foreign materials. Surgery 27: 220-234.
59. FOGARTY, U., D. PERL & P. GOOD. 1998. A cluster of equine granulomatous enteritis cases: the link with aluminium. Vet. Hum. Toxicol. 40: 297-305.
60. LERNER, A., S. ELURI, D. PERL, et al. 2006. Bacterial-aluminum interactions. The role of aluminum in bacterial-induced colitis in IL-10 deficient mice [abstract]. Gastroenterology 130: 362-363.
61. POWELL, J.J., R.S. HARVEY & R.P. THOMPSON. 1996. Microparticles in Crohn's disease - has the dust settled? Gut 39: 340-341.
62. LOMER, M.C., C. HUTCHINSON & S. VOLKERT. 2004. Dietary sources of inorganic microparticles and their intake in healthy subjects and patients with Crohn's disease. Br. J. Nutr. 92: 947-955.
63. POWELL, J.J., R.S. HARVEY & P. ASHWOOD. 2000. Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease. J. Autoimmun. 14: 99-105.
64. MANNHALTER, J.W, H.O NEYCHEV, G.J ZLABINGER, et al. 1985. Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation. Clin. Exp. Immunol. 61: 143-151.
65. EVANS, S.M., P. ASHWOOD & A. WARLEY. 2002. The role of dietary microparticles and calcium in apoptosis and interleukin-1beta release of intestinal macrophages. Gastroenterology 123: 1543-1553.
66. LUKIW, W.J., M.E. PERCY & T.P. KRUCK. 2005. Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture. J. Inorg. Biochem. 99: 1895-1898.
67. LOMER, M.C., R.S. HARVEY & S.M. EVANS. 2001. Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. Eur. J. Gastroenterol. Hepatol. 13: 101-106.
68. LOMER, M.C. & S.L. GRAINGER. 2004. Lack of efficacy of a reduced microparticle diet in a multi-centred trial of patients with active Crohn's disease. Eur. J. Gastroenterol. Hepatol. 17: 377-384.
69. GREEN, C., L. ELLIOTT, C. BEAUDOIN, et al. 2006. A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am. J. Epidemiol. 164: 615-623.
70. SARTOR, R.B. 2006. Microbial and dietary factors in the pathogenesis of chronic, immune-mediated intestinal inflammation. Adv. Exp. Med. Biol. 579: 35-54.
71. SARTOR, R.B. 2006. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 390-407.
72. SAITOH, H., K. TAKAGAKI, T. NAKAMURA, et al. 1996. Characterization of mucin in whole-gut lavage fluid obtained from patients with inflammatory bowel disease. Dig. Dis. Sci. 41: 1768-1774.
73. WARD, R.J., Y. ZHANG, R.R. CRICHTON. 2001. Aluminium toxicity and iron homeostasis. J. Inorg. Biochem. 87: 9-14.
74. VAN RENSBURG, S.J., F.C. POTOCNIK, J.N. DE VILLIERS, et al. 2000. Earlier age of onset of Alzheimer's disease in patients with both the transferrin C2 and apolipoprotein E-epsilon 4 alleles. Ann. N.Y. Acad. Sci. 903: 200-203.
75. FOSMIRE, G.J., S.J. FOCHT & G.E. MCCLEARN. 1993. Genetic influences on tissue deposition of aluminum in mice. Biol. Trace Elem. Res. 37: 115-121.
76. MORRIS, C.M., J.M. CANDY, A.E. OAKLEY, et al. 1989. Comparison of the regional distribution of transferrin receptors and aluminium in the forebrain of chronic renal dialysis patients. J. Neurol. Sci. 94: 295-306.
77. LOMER, M.C., K. KODJABASHIA, C. HUTCHINSON, et al. 2004. Intake of dietary iron is low in patients with Crohn's disease: a case-control study. Br. J. Nutr. 91: 141-148.
78. GIANNINI, S. & C. MARTES. 2006. Anemia in inflammatory bowel disease. Minerva Gastroenterol. Dietol. 52: 275-291.
79. REVEL-VILK, S., H. TAMARY, E. BROIDE, et al. 2000. Serum transferrin receptor in children and adolescents with inflammatory bowel disease. Eur. J. Pediatr. 159: 585-589.
80. AUTHIER, F.J., S. SAUVAT, C. CHRISTOV, et al. 2006. AlOH3-adjuvanted vaccine-induced macrophagic myofasciitis in rats is influenced by the genetic background. Neuromuscul. Disord. 16: 347-352.
81. D'INCA, R., V. ANNESE, V. DI LEO, et al. 2006. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease. Aliment. Pharmacol. Ther. 23: 1455-1461.
82. SCHREIBER, S. 2006. Slipping the barrier: how variants in CARD15 could alter permeability of the intestinal wall and population health. Gut 55: 308-309.
83. FRIES, W., M.C. RENDA, M.A. LO PRESTI, et al. 2005. Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy. Am. J. Gastroenterol. 100: 2730-2736.
84. HEGDE, M.L., S. ANITHA, K.S. LATHA, et al. 2004. First evidence for helical transitions in supercoiled DNA by amyloid beta peptide (1-42) and aluminum: a new insight in understanding Alzheimer's disease. J. Mol. Neurosci. 22: 19-31.
85. BANASIK, A., A. LANKOFF, A. PISKULAK, et al. 2005. Aluminum-induced micronuclei and apoptosis in human peripheral-blood lymphocytes treated during different phases of the cell cycle. Environ. Toxicol. 20: 402-406.
86. SAWA, T. & H. OHSHIMA. 2006. Nitrative DNA damage in inflammation and its possible role in carcinogenesis. Nitric Oxide 14: 91-100.
87. TAYLOR, C. & C. JOBIN. 2005. Ubiquitin protein modification and signal transduction: implications for inflammatory bowel diseases. Inflamm. Bowel Dis. 11: 1097-1107.
88. VAN KEMSEKE, C., J. BELAICHE & E. LOUIS. 2000. Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission. Int. J. Colorectal Dis. 15: 206-210.
89. BEUTLER, B. 2001. Autoimmunity and apoptosis: the Crohn's connection. Immunity 15: 5-14.
90. DIONNE, S., J. HISCOTT, I. D'AGATA, et al. 1997. Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies. Dig. Dis. Sci. 42: 1557-1566.
91. MIDDEL, P., D. RADDATZ, B. GUNAWAN, et al. 2006. Increased number of mature dendritic cells in Crohn's disease: evidence for a chemokine mediated retention mechanism. Gut 55: 220-227.
92. OLSON, T.S., G. BAMIAS, M. NAGANUMA, et al. 2004. Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn's disease. J. Clin. Invest. 114: 389-398.
93. EXLEY, C. 2004. The pro-oxidant activity of aluminum. Free Radic. Biol. Med. 36: 380-387.
94. KRUIDENIER, L., I. KUIPER, C.B. LAMERS. 2003. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J. Pathol. 201: 28-36.
95. MOEHLE, C., N. ACKERMANN, T. LANGMANN, et al. 2006. Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease. J. Mol. Med. 84: 1055-1066.
96. EXLEY, C. 1998. The precipitation of mucin by aluminium. J. Inorg. Biochem. 70: 195-206.